基本信息
- 会议时间： 2012年6月6日至2012年6月8日
- 会议地点： 上海
- 会议主题： 把握“十二五”重大新药创制的机遇，推动产学研合作，加速新药研发进程及科技成果转化
- 会议规模： 200-250人
- 大会邀请嘉宾：
- Ruiping Dong, Senior Vice President, Head of Emerging Market，Merck & Co
- Jingwu Zang, Senior Vice President, Head of R&D China，GlaxoSmithKline
- Arjun Oberoi, Vice President, Strategy & Business Development，Sanofi
- Kuiling Ding, Director-General，Shanghai Institute of Organic Chemistry, CAS
- Scott Simonet, Vice President, Metabolic Disorders Therapeutic Area, Amgen
- Zhong Zhong, Senior Director of Discovery Technology, GlaxoSmithKline
- Mingwei Wang, Director，The National Center for Drug Screening
- Alexander Mayweg, Head of Discovery Chemistry & Metabolic Chemistry Section，Roche R&D Center China
- Yi Yang, Head of Pre-Clinical Safety, China R&D, Director of Drug Safety Evaluation，Sanofi
- Gary Gintant, Senior Group Leader, Department of Integrative Pharmacology, Global Pharmaceutical Research & Development，Abbott Laboratories
- Clive Wood, Senior Vice President and Head of Global Biologics，Bayer HealthCare
- Michael Shi, Senior Director, Biomarker Project Leader, Oncology Translational Medicine ，Novartis
- Vincenzo Teneggi，Head of Early Development & Clinical Pharmacology, Asia Pacific， Roche R&D Center China
- 联系人： Shirley Zhang
- 联系电话： 86-21-5192 0620
- 电子邮箱： shirleyzh@innchinc.com
- 官方网站： http://www.innchinc.com/wpcs/
1月份
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息